BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 16007234)

  • 1. UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor.
    Calo G; Guerrini R; Rizzi A; Salvadori S; Burmeister M; Kapusta DR; Lambert DG; Regoli D
    CNS Drug Rev; 2005; 11(2):97-112. PubMed ID: 16007234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
    Calo G; Rizzi A; Rizzi D; Bigoni R; Guerrini R; Marzola G; Marti M; McDonald J; Morari M; Lambert DG; Salvadori S; Regoli D
    Br J Pharmacol; 2002 May; 136(2):303-11. PubMed ID: 12010780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 of nociceptin/orphanin FQ receptor.
    Peng YL; Chang M; Dong SL; Li W; Han RW; Fu GX; Chen Q; Wang R
    Regul Pept; 2006 May; 134(2-3):75-81. PubMed ID: 16516988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of [Arg14, Lys15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions.
    Broccardo M; Linari G; Guerrini R; Agostini S; Petrella C; Improta G
    Peptides; 2005 Sep; 26(9):1590-7. PubMed ID: 16112397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity.
    Guerrini R; Carra' G; Calo' G; Trapella C; Marzola E; Rizzi D; Regoli D; Salvadori S
    J Pept Res; 2004 Jun; 63(6):477-84. PubMed ID: 15175020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
    Carrà G; Rizzi A; Guerrini R; Barnes TA; McDonald J; Hebbes CP; Mela F; Kenigs VA; Marzola G; Rizzi D; Gavioli E; Zucchini S; Regoli D; Morari M; Salvadori S; Rowbotham DJ; Lambert DG; Kapusta DR; Calo' G
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1114-23. PubMed ID: 15509719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
    Leggett JD; Harbuz MS; Jessop DS; Fulford AJ
    Neuroscience; 2006 Sep; 141(4):2051-7. PubMed ID: 16784820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative study of [(pF)Phe4,Arg14,Lys15]nociceptin/orphanin FQ-NH2 (UFP-102) at NOP receptors in rat periaqueductal gray slices.
    Kuo CJ; Liao YY; Guerrini R; Calo' G; Chiou LC
    Eur J Pharmacol; 2008 Jan; 579(1-3):110-5. PubMed ID: 17976580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the nociceptin/orphanin FQ receptor reduces bronchoconstriction and microvascular leakage in a rabbit model of gastroesophageal reflux.
    D'Agostino B; Marrocco G; De Nardo M; Calò G; Guerrini R; Gallelli L; Advenier C; Rossi F
    Br J Pharmacol; 2005 Mar; 144(6):813-20. PubMed ID: 15685213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UFP-112 a potent and long-lasting agonist selective for the Nociceptin/Orphanin FQ receptor.
    Calo' G; Rizzi A; Cifani C; Micioni Di Bonaventura MV; Regoli D; Massi M; Salvadori S; Lambert DG; Guerrini R
    CNS Neurosci Ther; 2011 Jun; 17(3):178-98. PubMed ID: 20497197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nphe1,Arg14,Lys15]N/OFQ-NH2 is a competitive antagonist of NOP receptors in the periaqueductal gray.
    Chiou LC; Liao YY; Guerrini R; Calo' G
    Eur J Pharmacol; 2005 May; 515(1-3):47-53. PubMed ID: 15896734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: pharmacological and genetic evidences.
    Rizzi A; Nazzaro C; Marzola GG; Zucchini S; Trapella C; Guerrini R; Zeilhofer HU; Regoli D; Calo' G
    Pain; 2006 Sep; 124(1-2):100-8. PubMed ID: 16697109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior.
    Marti M; Mela F; Veronesi C; Guerrini R; Salvadori S; Federici M; Mercuri NB; Rizzi A; Franchi G; Beani L; Bianchi C; Morari M
    J Neurosci; 2004 Jul; 24(30):6659-66. PubMed ID: 15282268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors.
    Ibba M; Kitayama M; McDonald J; Calo G; Guerrini R; Farkas J; Toth G; Lambert DG
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Dec; 378(6):553-61. PubMed ID: 18807245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of nociceptin/orphanin FQ receptors, a novel opioid receptor family, in the midbrain periaqueductal gray.
    Chiou LC; Fan SH; Chuang KC; Liao YY; Lee SZ
    Ann N Y Acad Sci; 2004 Oct; 1025():398-403. PubMed ID: 15542742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats.
    Micheli L; Di Cesare Mannelli L; Guerrini R; Trapella C; Zanardelli M; Ciccocioppo R; Rizzi A; Ghelardini C; Calò G
    Eur J Pharmacol; 2015 May; 754():73-81. PubMed ID: 25704616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation.
    Trombella S; Vergura R; Falzarano S; Guerrini R; Calo G; Spisani S
    Peptides; 2005 Aug; 26(8):1497-502. PubMed ID: 15922491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor.
    Rizzi A; Spagnolo B; Wainford RD; Fischetti C; Guerrini R; Marzola G; Baldisserotto A; Salvadori S; Regoli D; Kapusta DR; Calo G
    Peptides; 2007 Jun; 28(6):1240-51. PubMed ID: 17532097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nociceptin/orphanin FQ receptor antagonist UFP-101 reduces microvascular inflammation to lipopolysaccharide in vivo.
    Brookes ZL; Stedman EN; Brown NJ; Hebbes CP; Guerrini R; Calo G; Reilly CS; Lambert DG
    PLoS One; 2013; 8(9):e74943. PubMed ID: 24086402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.